Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
20.85
P/B ratioShare price divided by book value per share.
2.75
P/S ratioMarket value divided by annual revenue.
3.76
PEG ratioP/E divided by the earnings growth rate.
2.51
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
14.50
EV / RevenueEnterprise value against annual revenue.
3.17
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
4.80%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
70.80%
Operating marginRevenue left after operating costs.
29.40%
Net marginRevenue left after every cost, including tax and interest.
17.93%
Return on equityProfit as a percentage of shareholders’ equity.
13.68%
Return on assetsProfit as a percentage of total assets.
7.88%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
6.22
Quick ratioThe same, excluding inventory.
5.27
Debt to equityTotal borrowings against shareholders’ equity.
0.01
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$1.09
Book value per shareShareholders’ equity divided by shares outstanding.
$8.26
Shares outstandingShares currently issued.
1,012,971,423
Market capitalisationShare price times shares outstanding.
$23.02B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
6,003
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
1.76%
Payout ratioShare of profit paid out as dividends.
What is Jiangsu Nhwa Pharmaceutical Co., LTD's P/E ratio?
Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) trades on a price-to-earnings ratio of 20.85.
What is Jiangsu Nhwa Pharmaceutical Co., LTD's return on equity?
Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) reports a return on equity of 13.68%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Jiangsu Nhwa Pharmaceutical Co., LTD carry?
Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) has a debt-to-equity ratio of 0.01, which compares total borrowings with shareholders' equity.
What is Jiangsu Nhwa Pharmaceutical Co., LTD's profit margin?
Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) keeps 17.93% of revenue as net profit after every cost, including tax and interest.